Interventions for Tuberculosis Control and Elimination 2002

1053. Thomas L, Naumann P, Crea A. In-vitro-Aktivität von Ciprofloxacin und
Ofloxacin gegen Mycobacterium tuberculosis, M. avium, M. africum, M. kansasii
und BCG-Stämme. Immun Infekt 1986; 14: 203-7.
1054. Heifets LB, Lindholm-Levy PJ. Bacteriostatic and bactericidal activity of
ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and
Mycobacterium avium complex. Tubercle 1987; 68: 267-76.
1055. Young LS, Berlin OGW, Inderlied CB. Activity of ciprofloxacin and other fluorinated
quinolones against mycobacteria. Am J Med 1967; 82: 23-6.
1056. Sirgel FA, Botha FJ, Parkin DP, Van de Wal BW, Schall R, Donald PR,
Mitchison DA. The early bactericidal activity of ciprofloxacin in patients with
pulmonary tuberculosis. Am J Respir Crit Care Med 1997; 156: 901-5.
1057. Hohl P, Salfinger M, Kafader FM. In vitro activity of the new quinolone RO
23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247
(T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
J Clin Microbiol 1987; 6: 487-8.
Eur
1058. Tomioka H, Sato K, Akaki T, Kajitani H, Kawahara S, Sakatani M. Comparative
in vitro antimicrobial activities of the newly synthesized quinolone HSR-903,
sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against
Mycobacterium tuberculosis and Mycobacterium avium complex.
Agents Chemother 1999; 43: 3001-4.
Antimicrob
1059. Peloquin CA, Berning SE, Huitt GA, Iseman MD. Levofloxacin for drug-resistant
Mycobacterium tuberculosis.
32: 268.
(Correspondence). Ann Pharmacother 1998;
1060. Ji B, Lounis N, Truffot-Pernot C, Grosset J. In vitro and in vivo activities of
levofloxacin against Mycobacterium tuberculosis.
1995; 39: 1341-4.
Antimicrob Agents Chemother
1061. Ji B, Lounis N, Maslo C, Truffot-Pernot C, Bonnafous P, Grosset J. In vitro
and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium
tuberculosis. Antimicrob Agents Chemother 1998; 42: 2066-9.
1062. Piersimoni C, Morbiducci V, Bornigia S, De Sio G, Scalise G. In vitro activity
of the new quinolone lomefloxacin against Mycobacterium tuberculosis.
Rev Respir Dis 1992; 146: 1445-7.
Am
1063. Gillespie SH, Billington O. Activity of moxifloxacin against mycobacteria.
J Antimicrob Chemother 1999; 44: 393-5.
1064. Tsukamura M. Antituberculosis activity of ofloxacin (DL 8280) on experimenal
tuberculosis in mice. Am Rev Respir Dis 1985; 132: 915.
1065. Mangunnegoro H, Hudoyo A. Efficacy of low-dose ofloxacin in the treatment
of multidrug-resistant tuberculosis in Indonesia.
19-25.
Chemotherapy 1999; 45(suppl 2):
1066. Alegre J, Fernandez de Sevilla T, Falcò V, Martinez Vazquez JM. Ofloxacin
in miliary tuberculosis. Eur Respir J 1990; 3: 238-9.
240